Cocrystal Pharma, Inc. Financial Ratios — COCP Stock

Profitability (USD)

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Return on Common Equity (%)	- -	- -	- -	- -	-57.53	-55.48	-0.59	-56.94	-104.04	-24.67	-21.81	-66.32	-54.54	-97.5	-111.4
Return on Assets (%)	-72.38	-107.73	-87.34	-0.08	-20.73	-42.89	-0.5	-51.63	-99.22	-23.31	-21.23	-64.6	-49.89	-78.29	-76.23
Return on Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Return on Invested Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Gross Margin (%)	21.31	- -	- -	100	100	- -	- -	- -	100	100	- -	- -	- -	- -	- -
EBITDA Margin (%)	-26.62	- -	- -	-62,222.22	-68,917.95	- -	- -	- -	-33.59	-468.17	- -	- -	- -	- -	- -
Operating Margin (%)	-30.84	- -	- -	-64,433.33	-69,164.1	- -	- -	- -	-35.09	-475.97	- -	- -	- -	- -	- -
Incremental Operating Margin (%)	- -	-10.58	- -	- -	- -	66,501.28	- -	- -	- -	- -	230.14	- -	- -	- -	- -
Pretax Margin (%)	-43.27	- -	- -	-1,677.78	-83,807.69	- -	- -	- -	-733.84	-479.05	- -	- -	- -	- -	- -
Profit Margin (%)	-43.29	- -	- -	-1,100	-64,258.97	- -	- -	- -	-733.84	-479.05	- -	- -	- -	- -	- -
Net Income to Common Margin (%)	-43.29	- -	- -	-1,100	-64,258.97	- -	- -	- -	-733.84	-479.05	- -	- -	- -	- -	- -
Effective Tax Rate (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Dvd Payout Ratio (%)	- -	- -	51.55	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Sustainable Growth Rate (%)	- -	- -	- -	- -	-57.53	-55.48	-0.59	-56.94	-104.04	-24.67	-21.81	-66.32	-54.54	-97.5	-111.4

Credit (USD)

Credit Ratios API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Total Debt	6	4	- -	- -	- -	- -	1	- -	1	1	1	- -	2	2	2
ST Debt	3	1	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
LT Debt	3	3	- -	- -	- -	- -	1	- -	1	- -	- -	- -	2	2	1
Total Debt/EBITDA	-1.92	-1.81	- -	- -	- -	- -	-0.12	-0.04	-0.37	-0.06	-0.04	-0.02	-0.08	-0.1	-0.17
Net Debt/EBITDA	-1.8	-1.8	0.27	0.71	0.17	0.03	-0.03	0.3	3.36	3.5	4.24	2.09	1.17	0.57	0.81
Total Debt/EBIT	-1.66	-1.71	- -	- -	- -	- -	-0.12	-0.04	-0.35	-0.06	-0.04	-0.02	-0.09	-0.1	-0.17
Net Debt/EBIT	-1.55	-1.71	0.25	0.68	0.17	0.03	-0.03	0.3	3.22	3.44	4.13	2.05	1.25	0.55	0.78
EBITDA to Interest Expense	-2.7	-0.46	-1.15	- -	- -	- -	- -	-154.64	-116.05	-1,178.62	-3,459.75	-8,874.5	- -	- -	- -
EBITDA-CapEx/Interest Expense	-3.16	-0.49	-1.15	- -	- -	- -	- -	-155.12	-123.68	-1,208.62	-3,472.75	-8,911.5	- -	- -	- -
EBIT to Interest Expense	-3.13	-0.49	-1.22	- -	- -	- -	- -	-155.5	-121.21	-1,198.25	-3,555.25	-9,068.5	- -	- -	- -
Interest Expense	1	5	3	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Common Equity/Total Assets	-36.69	-49.45	-531.79	2.57	74.74	81.93	86.8	97.56	90.11	96.8	97.68	96.88	84.4	70.77	65.19
Long-Term Debt/Equity (%)	- -	- -	- -	- -	- -	- -	0.96	0.17	2.09	0.72	0.38	0.14	6.11	15.8	18.5
Long-Term Debt/Capital (%)	82.57	368.08	- -	- -	- -	- -	0.95	0.17	2.02	0.71	0.38	0.14	5.71	13.28	14.94
Long-Term Debt/Total Assets (%)	40.25	39.98	- -	- -	- -	- -	0.83	0.17	1.88	0.7	0.38	0.14	5.16	11.18	12.06
Total Debt/Equity (%)	-232.86	-121.96	- -	- -	- -	- -	0.96	0.49	3.18	1.14	0.69	0.75	7.02	18.96	23.77
Total Debt/Capital (%)	175.27	555.28	- -	- -	- -	- -	0.95	0.49	3.08	1.12	0.68	0.75	6.56	15.94	19.21
Total Debt/Total Assets (%)	85.44	60.32	- -	- -	- -	- -	0.83	0.48	2.86	1.1	0.67	0.73	5.93	13.42	15.5
Net Debt to Equity	-217.82	-121.74	11.71	-59.69	-5.53	-3.52	0.25	-4.07	-28.85	-62.87	-75.7	-93.88	-99.88	-103.54	-110.96
Net Debt/Capital (%)	184.88	560.02	10.48	-148.08	-5.86	-3.65	0.25	-4.22	-38.82	-164.3	-302.95	-1,365.59	-1,398.78	-671.2	-866.21
EBITDA	-3	-2	-4	-6	-54	-106	-8	-9	-2	-9	-14	-18	-23	-17	-9
EBITDA-CapEx	-4	-3	-4	-6	-54	-106	-8	-9	-2	-10	-14	-18	-23	-17	-9
Operating Income (Loss)	-4	-3	-4	-6	-54	-106	-8	-9	-2	-10	-14	-18	-21	-18	-9

Liquidity (USD)

Liquidity Ratios API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Cash Ratio	0.06	- -	2.68	0.65	1.38	1.77	0.52	1.75	3.24	24.31	38	30.55	8.08	4.06	3.18
Current Ratio	0.4	0.62	3.04	0.7	1.48	2.68	1.51	1.89	3.62	25.05	38.4	33.04	8.92	4.77	3.68
Quick Ratio	0.13	0.08	2.68	0.68	1.41	2.41	1.42	1.75	3.53	24.72	38	31.13	8.35	4.56	3.5
CFO/Avg Current Liab	-0.07	-0.18	-0.66	-1.26	-1.3	-3.35	-3.97	-5.54	-0.81	-5.4	-8.76	-15.53	-6.55	-5.79	-3.53
Common Equity/Total Assets	-36.69	-49.45	-531.79	2.57	74.74	81.93	86.8	97.56	90.11	96.8	97.68	96.88	84.4	70.77	65.19
Long-Term Debt/Equity (%)	- -	- -	- -	- -	- -	- -	0.96	0.17	2.09	0.72	0.38	0.14	6.11	15.8	18.5
Long-Term Debt/Capital (%)	82.57	368.08	- -	- -	- -	- -	0.95	0.17	2.02	0.71	0.38	0.14	5.71	13.28	14.94
Long-Term Debt/Total Assets (%)	40.25	39.98	- -	- -	- -	- -	0.83	0.17	1.88	0.7	0.38	0.14	5.16	11.18	12.06
Total Debt/Equity (%)	-232.86	-121.96	- -	- -	- -	- -	0.96	0.49	3.18	1.14	0.69	0.75	7.02	18.96	23.77
Total Debt/Capital (%)	175.27	555.28	- -	- -	- -	- -	0.95	0.49	3.08	1.12	0.68	0.75	6.56	15.94	19.21
Total Debt/Total Assets (%)	85.44	60.32	- -	- -	- -	- -	0.83	0.48	2.86	1.1	0.67	0.73	5.93	13.42	15.5
CFO/Total Liabilities	-4.08	-14.68	-35.12	-2.38	-18.22	-64.95	-43.07	-495.22	-55.37	-565.92	-690.12	-1,683.82	-300.84	-419.15	-242.3
CFO/CapEx	-0.73	-10.44	-921.5	-1,202.4	-30.43	-287.35	-172.58	-296.07	-10.78	-40.96	-244.6	-289.66	-124.29	-2,060.62	-682.67
Altman's Z-Score	9.56	5.87	-13.77	-4.25	-14	-85.54	-88.97	-47.51	-30.51	23.61	14.98	-3.05	-13.24	-35.12	-49.27

Working Capital (USD)

Working Capital Ratios API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Accounts Receivable Turnover	13.13	- -	- -	0.15	1.01	- -	- -	- -	20.39	3.36	- -	- -	- -	- -	- -
Days Sales Outstanding	27.8	- -	- -	2,473.89	360.32	- -	- -	- -	17.91	108.74	- -	- -	- -	- -	- -
Inventory Turnover	4.59	5.74	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Days Inventory Outstanding	79.5	63.54	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Accounts Payable Turnover	7.16	8.33	-3.44	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Accounts Payable Turnover Days	50.98	43.82	-106.14	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Cash Conversion Cycle	56.32	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Inventory to Cash Days	-51.69	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Inventories	2	2	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Raw Materials	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Work In Process	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Finished Goods	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Other Inventory	2	2	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -

Enterprise Value (USD)

Enterprise Value API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Market Capitalization	203	205	73	51	618	278	146	108	18	96	63	16	17	21	13
- Cash & Cash Equivalents	- -	- -	1	4	9	4	1	3	7	33	59	37	26	10	7
+ Preferred Equity and Hybrid Capital	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Minority/Non Controlling Interest	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Total Debt	6	4	- -	- -	- -	- -	1	- -	1	1	1	- -	2	2	2
Enterprise Value	209	210	72	46	609	275	146	105	11	63	5	-21	-7	12	8
Total Capital	4	1	-9	7	168	102	106	67	27	53	78	40	28	11	8
Total Debt/Capital (%)	175.27	555.28	- -	- -	- -	- -	0.95	0.49	3.08	1.12	0.68	0.75	6.56	15.94	19.21
Total Debt / EV	0.03	0.02	- -	- -	- -	- -	0.01	- -	0.07	0.01	0.1	-0.01	-0.26	0.14	0.19
EV/Sales	16.59	- -	- -	5,055.76	7,804.23	- -	- -	- -	1.67	31.47	- -	- -	- -	- -	- -
EV/EBITDA	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/EBIT	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/Cash Flow to Firm	254.17	57.54	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/Free Cash Flow to Firm	149.56	55.23	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Diluted Market Cap	203	205	73	51	562	276	145	101	16	75	57	16	17	21	11
Diluted Enterprise Value	209	210	72	47	552	272	145	98	9	43	-1	-21	-8	12	6
EV per Share	1,364.15	1,194.85	227.13	133.73	315.59	138.58	72.13	42.24	3.75	10.8	0.64	- -	- -	1.23	0.58
TTM Sales	13	- -	- -	- -	- -	- -	- -	- -	7	2	- -	- -	- -	- -	- -
TTM EBITDA	-3	-2	-4	-6	-54	-106	-8	-9	-2	-9	-14	-18	-23	-17	-9
TTM Operating Income	-4	-3	-4	-6	-54	-106	-8	-9	-2	-10	-14	-18	-21	-18	-9
TTM Cash Flow to Firm	1	4	- -	-6	-10	-15	-7	-8	-2	-10	-13	-21	-15	-16	-8
TTM Free Cash Flow to Firm	1	4	- -	-6	-10	-15	-7	-8	-1	-10	-13	-21	-15	-16	-8

Multiples (USD)

Valuation Multiples API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Price/Free Cash Flow	1,314.53	-142.84	-19.8	-8.56	-56.28	-18.87	-21.09	-12.2	-11.23	-7.83	-4.53	-0.74	-1.14	-1.25	-1.35
EV/EBIT	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Enterprise Value	209	210	72	46	609	275	146	105	11	63	5	-21	-7	12	8
Low Price	37.8	183.6	75.6	90	144	115.2	57.6	18.12	4.68	5.4	7.68	1.74	1.38	1.33	0.9
EV/Sales	16.59	- -	- -	5,055.76	7,804.23	- -	- -	- -	1.67	31.47	- -	- -	- -	- -	- -
EV/EBITDA	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Earnings	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Earnings Average	-28.25	-21.41	-15.8	-547.11	-11.01	-5.1	-308.54	-2.08	-1.4	-6.43	-7.62	-1.01	-1.2	-1.09	-1.9
Price/Earnings High	-55.61	-31.71	-53.26	-915.6	-19.26	-8.68	-484.09	-3.94	-3.49	-17.4	-21.55	-1.86	-1.77	-1.89	-3.41
Price/Earnings Low	-1.06	-4.04	-2.98	-309.32	-5.04	-3.02	-188.91	-0.86	-0.26	-2.58	-3.99	-0.36	-0.74	-0.77	-1.15
Price/Book Value	-73.33	-57.32	-8.26	7.74	3.69	2.72	1.38	1.61	0.68	1.82	0.82	0.4	0.66	2.16	2.13
Price/Book Value Average	-55.67	-47.63	-14.35	8.14	3.62	3.77	1.81	1.63	2.89	1.51	1.54	0.99	0.86	1.99	3.23
Price/Book Value High	-109.6	-70.54	-48.37	13.63	6.34	6.42	2.83	3.09	7.22	4.08	4.35	1.83	1.27	3.48	5.81
Price/Book Value Low	-2.09	-8.99	-2.71	4.6	1.66	2.23	1.11	0.68	0.53	0.6	0.8	0.36	0.53	1.42	1.96
Price/Tangible Book Value	-50.22	-42.77	-8.26	-0.21	-14.08	-16.59	-10.63	63.66	2.66	2.87	1.08	0.4	0.66	2.16	2.13
Price/Tangible Book Value Average	-38.12	-35.54	-14.35	-0.22	-13.84	-23.02	-13.89	64.31	11.25	2.37	2.04	0.99	0.86	1.99	3.23
Price/Tangible Book Value High	-75.06	-52.64	-48.37	-0.37	-24.2	-39.15	-21.79	122.02	28.05	6.41	5.77	1.83	1.27	3.48	5.81
Price/Tangible Book Value Low	-1.43	-6.71	-2.71	-0.13	-6.33	-13.62	-8.51	26.7	2.07	0.95	1.07	0.36	0.53	1.42	1.96
Price/Sales	16.11	- -	- -	5,716.32	7,199.35	- -	- -	- -	2.43	37.29	- -	- -	- -	- -	- -
Price/Sales Average	12.23	- -	- -	6,018.23	7,076.41	- -	- -	- -	10.27	30.82	- -	- -	- -	- -	- -
Price/Sales High	24.08	- -	- -	10,071.61	12,376.41	- -	- -	- -	25.63	83.35	- -	- -	- -	- -	- -
Price/Sales Low	0.46	- -	- -	3,402.57	3,235.66	- -	- -	- -	1.89	12.34	- -	- -	- -	- -	- -
Price/Cash Flow	-482.39	-129.16	-19.78	-8.56	-54.43	-18.79	-20.97	-12.16	-10.19	-7.64	-4.52	-0.74	-1.13	-1.25	-1.35
Price/Cash Flow Average	-366.19	-107.33	-34.39	-9.01	-53.5	-26.07	-27.4	-12.29	-43.15	-6.32	-8.5	-1.82	-1.47	-1.15	-2.04
Price/Cash Flow High	-720.97	-158.97	-115.92	-15.08	-93.57	-44.34	-42.99	-23.31	-107.62	-17.08	-24.04	-3.37	-2.16	-2.01	-3.68
Price/Cash Flow Low	-13.76	-20.27	-6.49	-5.09	-24.46	-15.42	-16.78	-5.1	-7.95	-2.53	-4.45	-0.66	-0.91	-0.82	-1.24
Price/Free Cash Flow Average	997.88	-118.7	-34.42	-9.02	-55.32	-26.18	-27.56	-12.33	-47.56	-6.47	-8.53	-1.83	-1.48	-1.15	-2.05
Price/Free Cash Flow High	1,964.64	-175.8	-116.04	-15.09	-96.75	-44.52	-43.24	-23.39	-118.63	-17.5	-24.14	-3.39	-2.18	-2.01	-3.69
Price/Free Cash Flow Low	37.51	-22.41	-6.5	-5.1	-25.29	-15.48	-16.87	-5.12	-8.76	-2.59	-4.46	-0.66	-0.92	-0.82	-1.24
EV/Sales Average	12.71	- -	- -	5,577.12	7,668.93	- -	- -	- -	10.33	23.23	- -	- -	- -	- -	- -
EV/Sales High	24.56	- -	- -	9,630.5	13,501.78	- -	- -	- -	27.27	90.23	- -	- -	- -	- -	- -
EV/Sales Low	0.94	- -	- -	2,961.46	3,442.05	- -	- -	- -	1.08	- -	- -	- -	- -	- -	- -
EV/EBITDA Average	-47.74	-72.42	-32.7	-8.96	-11.13	-3.62	-23.35	-11.87	-30.75	-4.96	-4.41	-0.12	0.08	-0.63	-1.73
EV/EBITDA High	-92.25	-106.39	-110.85	-15.48	-19.59	-6.19	-36.62	-22.77	-81.18	-19.27	-20.17	-2	-0.4	-1.44	-3.62
EV/EBITDA Low	-3.52	-15.14	-5.95	-4.76	-4.99	-2.13	-14.31	-4.77	-3.22	0.08	-0.3	1.28	0.46	-0.31	-0.8
EV/EBIT Average	-41.21	-68.49	-30.8	-8.66	-11.09	-3.62	-23.06	-11.81	-29.44	-4.88	-4.29	-0.12	0.08	-0.61	-1.65
EV/EBIT High	-79.63	-100.62	-104.44	-14.95	-19.52	-6.17	-36.17	-22.64	-77.72	-18.96	-19.62	-1.96	-0.42	-1.4	-3.47
EV/EBIT Low	-3.04	-14.32	-5.61	-4.6	-4.98	-2.13	-14.13	-4.75	-3.09	0.07	-0.3	1.25	0.49	-0.31	-0.76
Last Price	1,324.8	1,170	230.4	151.2	320.4	140.4	72	43.2	6	16.32	7.8	1.95	1.72	2.02	0.98
High Price	1,980	1,440	1,350	266.4	550.8	331.2	147.6	82.8	63.36	36.48	41.52	8.88	3.29	3.26	2.67
Enterprise Value Average	160	175	126	50	598	383	191	106	68	47	61	2	-2	11	15
Enterprise Value High	310	257	426	87	1,053	653	299	204	179	182	279	35	9	25	31
Enterprise Value Low	12	37	23	27	268	225	117	43	7	-1	4	-23	-10	5	7

Shares Outstanding	- -	- -	- -	- -	2	2	2	2	3	6	8	8	10	10	14
Diluted Weighted Avg Shares	- -	- -	- -	- -	2	2	2	2	3	5	7	8	10	10	11
Basic Weighted Avg Shares	- -	- -	- -	- -	2	2	2	2	3	5	7	8	10	10	11
Revenue per Share	82.24	- -	- -	0.03	0.04	- -	- -	- -	2.47	0.44	- -	- -	- -	- -	- -
EBITDA per Share	-21.89	-13.77	-12.15	-16.46	-30.67	-53.84	-4.06	-3.84	-0.83	-2.05	-1.88	-2.18	-2.34	-1.71	-0.77
Operating Income per Share	-25.36	-14.56	-12.89	-17.04	-30.78	-53.94	-4.11	-3.86	-0.87	-2.08	-1.93	-2.23	-2.19	-1.76	-0.8
Basic EPS, GAAP	-35.6	-45.41	-25.35	-0.29	-28.6	-38.17	-0.3	-21.01	-18.14	-2.1	-1.93	-4.77	-1.86	-1.72	-0.78
Basic EPS from Cont Ops	-35.6	-43.51	-12.28	-0.29	-28.6	-38.17	-0.3	-21.01	-18.14	-2.1	-1.93	-4.77	-1.86	-1.72	-0.78
Diluted EPS, GAAP	-35.6	-45.41	-25.35	-0.29	-28.6	-38.14	-0.3	-21.01	-18.14	-2.1	-1.93	-4.77	-1.86	-1.72	-0.78
Diluted EPS from Cont Ops	-35.6	-43.51	-12.28	-0.29	-28.6	-38.14	-0.3	-21.01	-18.14	-2.1	-1.93	-4.77	-1.86	-1.72	-0.78
Dividend per Share	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Cash Flow per Share	-2.75	-9.06	-11.65	-17.67	-5.89	-7.47	-3.43	-3.55	-0.59	-2.14	-1.73	-2.63	-1.52	-1.62	-0.73
Free Cash Flow per Basic Share	-6.5	-9.93	-11.66	-17.68	-6.08	-7.5	-3.45	-3.56	-0.64	-2.19	-1.73	-2.64	-1.53	-1.62	-0.73
Cash & Equivalents per Share	2.72	0.05	3.27	17.47	4.81	1.82	0.37	1.09	2.53	5.62	7.23	4.56	2.59	0.97	0.51
Book Value per Share	-18.07	-20.41	-27.91	19.55	86.89	51.59	52.1	26.81	8.78	8.94	9.55	4.86	2.59	0.94	0.46
Tangible Book Value per Share	-26.38	-27.36	-27.91	-715.66	-22.76	-8.46	-6.77	0.68	2.26	5.69	7.2	4.86	2.59	0.94	0.46

Cocrystal Pharma, Inc.

Profitability (USD)

Credit (USD)

Liquidity (USD)

Working Capital (USD)

Enterprise Value (USD)

Multiples (USD)

Per Share Data Items (USD)